Rame H Khasawneh (Rame Khasawneh)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Ejection Fraction

Cardiovascular Disease

Genome Wide Association

Venous Thromboembolism

Top Venues

International journal of general medicine

OncoTargets and therapy

Pharmacogenomics and personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mansour Abdullah Alghamdi, Laith Naser Al-Eitan, Rami Alkhatib, Ahmad Al-Assi, Ayah Almasri, Hanan A Aljamal, Hatem Aman, Rame H Khasawneh
Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease. International journal of general medicine 14 (2021)
Rasheed K Ibdah, Laith Naser Al-Eitan, Nasr N Alrabadi, Ayah Y Almasri, Adan H Alnaamneh, Rame H Khasawneh, Mansour Abdullah Alghamdi
Impact of PCSK9, WDR12, CDKN2A, and CXCL12 Polymorphisms in Jordanian Cardiovascular Patients on Warfarin Responsiveness and Sensitivity. International journal of general medicine 14 (2021)
Laith Naser Al-Eitan, Barakat Z Elsaqa, Ayah Y Almasri, Hatem A Aman, Rame H Khasawneh, Mansour Abdullah Alghamdi
Influence of PSRC1, CELSR2, and SORT1 Gene Polymorphisms on the Variability of Warfarin Dosage and Susceptibility to Cardiovascular Disease. Pharmacogenomics and personalized medicine 13 (2020)
Laith Naser Al-Eitan, Doaa M Rababa'h, Mansour Abdullah Alghamdi, Rame H Khasawneh
Genetic association of XRCC5 gene polymorphisms with breast cancer among Jordanian women. OncoTargets and therapy 12 (2019)
Laith Naser Al-Eitan, Ayah Y Almasri, Rame H Khasawneh
Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy. Genes 9 (12) (2018)